Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity (Q34330489)

1 August 2017

Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity (English)

1 reference

1 August 2017

0 references

Nuria Vilarrasa

3

0 references

author name string

Joan Vendrell

1

1 reference

1 August 2017

Montserrat Broch

2

1 reference

1 August 2017

Ana Molina

4

1 reference

1 August 2017

Jose Manuel Gómez

5

1 reference

1 August 2017

Cristina Gutiérrez

6

1 reference

1 August 2017

Immaculada Simón

7

1 reference

1 August 2017

Joan Soler

8

1 reference

1 August 2017

Cristóbal Richart

9

1 reference

1 August 2017

1 June 2004

1 reference

1 August 2017

1 reference

1 August 2017

12

1 reference

1 August 2017

6

1 reference

1 August 2017

962-971

1 reference

Genotype, obesity and cardiovascular disease--has technical and social advancement outstripped evolution?

1 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Obesity and the risk for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Genetics and pathophysiology of human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

An adipocentric view of signaling and intracellular trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Effect of surgically-induced weight loss on leukocyte indicators of chronic inflammation in morbid obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Is obesity an inflammatory condition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Minireview: Adiposity, Inflammation, and Atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

A novel serum protein similar to C1q, produced exclusively in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Association of hypoadiponectinemia with impaired vasoreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

The hormone resistin links obesity to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Resistin gene expression in human adipocytes is not related to insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Ghrelin induces adiposity in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Improved beta-cell function after standardized weight reduction in severely obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Evolution of operative procedures for the management of morbid obesity 1950-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Plasma soluble tumor necrosis factor alpha receptors and leptin levels in normal-weight and obese women: effect of adiposity and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Insulin resistance, leptin and TNF-alpha system in morbidly obese women after gastric bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Adiponectin gene activation by thiazolidinediones requires PPAR gamma 2, but not C/EBP alpha-evidence for differential regulation of the aP2 and adiponectin genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Weight loss increases circulating levels of ghrelin in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Serum ghrelin levels in response to glucose load in obese subjects post-gastric bypass surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Different plasma ghrelin levels after laparoscopic gastric bypass and adjustable gastric banding in morbid obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Direct peripheral effects of ghrelin include suppression of adiponectin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Humoral regulation of resistin expression in 3T3-L1 and mouse adipose cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Serum Resistin (FIZZ3) Protein Is Increased in Obese Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Brain pathways controlling food intake and body weight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Reducing early technical complications in gastric bypass surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Validation of tetrapolar bioelectrical impedance method to assess human body composition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Glycemic status and soluble tumor necrosis factor receptor levels in relation to plasma leptin concentrations among normal weight and overweight US men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Tumour necrosis factor-alpha exerts dual effects on human adipose leptin synthesis and release

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Autocrine inhibition of leptin production by tumor necrosis factor-alpha (TNF-alpha) through TNF-alpha type-I receptor in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Relationship between plasma leptin levels and the tumor necrosis factor-alpha system in obese subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Tumor necrosis factor (TNF)-alpha induces leptin production through the p55 TNF receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

Plasma ghrelin concentratin in the short-term following biliopancreatic diversion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.118

31 March 2020

Identifiers

DOI

10.1038/OBY.2004.118

1 reference

1 August 2017

1 reference